N-Heterocyclic
carbene and phosphine can be labeled as solid σ-donor
ligands and can contribute to stable complexes. In addition, the constructed
complex can accommodate a wide variety of applications, such as pharmaceutical
products. In the light of this, a theoretical analysis was carried
out on the existence of metal–drug interactions of group 11
metal ions in coordination with symmetrical unsaturated N-heterocyclic
carbenes [NHC(R)(R′)] and monodentate phosphine (PR
3
). The R substitutes on N atoms in NHC and phosphines are identical,
and R′ substitutes are located on two noncarbenic carbon atoms
(C4 and C5) in the heterocycle complexes. All complexes are in general
formula, [Tgt → ML] {where M = Cu(I), Ag(I), Au(I), Tgt = 2,3,4,6-tetra-
O
-acetyl-1-thio-β-
d
-glucopyranoside, L= [NHC(R)(R′)],
and PR
3
; R = F, Cl, Br, H, CH
3
, C
2
H
5
, SiH
3
, 2,6-diisopropylphenyl; R′
= H and Ph} at the PBE-D3/def2-TZVP level of theory. Findings show
greater tolerance for the release of drugs in the presence of Ag(I)
metal ions than the other metal ions studied here. Applying natural
bond orbital (NBO), atoms in molecules (AIMs), energy decomposition
analysis (EDA), and extended transition-state natural orbital for
chemical valence (ETS-NOCV) analysis have been researched in order
to ascertain the nature of M ← S and M ← C (M ←
P) bonds in the complexes. Results have shown that σ donation
from S to M atoms in [Tgt → MPR
3
] complexes is better
and the π acceptor is weaker than the corresponding [Tgt →
MNHC(R)(R′)] complexes.